The Ebola vaccine that scientists have been struggling to come up with in the battle against the fatal disease has just undergone the first testing phase and proves amazing potential. So far, the Ebola outbreak in West Africa has caused nearly 16,000 cases of infection, and 5,674 deaths over the territory of the three countries most affected by it - Liberia, Sierra Leone and Guinea. Given the … [Read more...]
Merck Buys Rights to Experimental Ebola Vaccine
Merck & Co., the second largest U.S. drugmaker, announced that it will buy commercial rights for an experimental Ebola vaccine developed by NewLink Genetics Corp. Merck will split the total of $50 million in two payments. First, the buyer will offer $30 million upfront. When the next stage of clinical trials will be completed in the first months of 2015, Merck will pay the remaining $20 … [Read more...]
WHO: 200,000 Ebola Vaccine Doses Available by Mid-2015
The World Health Organization speeds up the efforts to contain the Ebola outbreak in West Africa. During a press conference, Dr Marie Paule Kieny, a WHO assistant director-general, said they expect several hundred thousand vaccines to be ready by mid-2015. Kieny said that "While we hope that the massive response, which has been put in place will have an impact on the epidemic, it is still … [Read more...]
Ebola Vaccine Available Soon
The Geneva, Switzerland-based World Health Organization chose two Ebola vaccines as the most promising candidates in the fight against the deadly virus. One of them, called rVSV, is developed by the Canadian National Microbiology Laboratory in Winnipeg. GlaxoSmithKline, a British pharma company, makes the other promising vaccine, ChAd3. Either way, we will have an Ebola vaccine available … [Read more...]
Canada Will Donate Ebola Vaccine to WHO
Canada has announced that it would donate around 1,000 doses of an experimental Ebola vaccine to help control the outbreak of the disease in West Africa. The news comes after the World Health Organization states that it believes using untested drugs on Ebola patients to be ethical. The supplies are limited and experts believe that it could take months to develop more doses of the Ebola vaccine … [Read more...]
GSK Ebola Vaccine Going into Clinical Trials Soon
Considering the acute situation in which West Africa finds itself, drug manufacturers now face the situation of having to start clinical trials on experimental drugs. As such, GlaxoSmithKline has announced that it will start the clinical trial for its vaccine against the Ebola virus. The British drug manufacturer has been developing this vaccine together with U.S. scientists and because of the … [Read more...]
